IsoRay

$1.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-16.12%) Today
$0.00 (0.00%) As of 9:02 PM UTC after-hours

Why Robinhood?

You can buy or sell IsoRay and other stocks, options, and ETFs commission-free!

About ISR

IsoRay, Inc., also called IsoRay, is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. The listed name for ISR is IsoRay, Inc.

CEO
Lori A. Woods
Employees
53
Headquarters
Richland, Washington
Founded
1983
Market Cap
141.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
8.96M
High Today
$1.20
Low Today
$0.9505
Open Price
$1.14
Volume
13.79M
52 Week High
$2.81
52 Week Low
$0.352

ISR Earnings

-$0.02
-$0.01
-$0.01
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected May 11, After Hours

You May Also Like

GXGXU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure